Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125868892 | 12586889 | 2 | F | 20151021 | 20160824 | 20160725 | 20160825 | EXP | GB-ROCHE-1800260 | ROCHE | 53.00 | YR | M | Y | 0.00000 | 20160825 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125868892 | 12586889 | 1 | PS | RIBAVIRIN. | RIBAVIRIN | 1 | Unknown | U | 21511 | 600 | MG | BID | |||||||
| 125868892 | 12586889 | 2 | SS | HARVONI | LEDIPASVIRSOFOSBUVIR | 1 | Unknown | U | 0 | 1 | DF | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125868892 | 12586889 | 1 | Chronic hepatitis C |
| 125868892 | 12586889 | 2 | Chronic hepatitis C |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125868892 | 12586889 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125868892 | 12586889 | Drug ineffective | |
| 125868892 | 12586889 | Hepatitis C |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125868892 | 12586889 | 1 | 201501 | 20150627 | 0 | |
| 125868892 | 12586889 | 2 | 201501 | 20150627 | 0 |